Foghorn Therapeutics Inc. · NASDAQ:FHTX
Flagship Ventures Fund V, L.P. reported a 15.90% stake in Foghorn Therapeutics Inc. (Schedule 13D/A)
Event Jan 9, 2026 · Filed Jan 13, 2026
Flagship Ventures Fund V, L.P. reported a 15.90% stake in Foghorn Therapeutics Inc., 9,330,878 shares, with active intent on Jan 9, 2026. Filed Jan 13, 2026 (Schedule 13D/A).
- Stake
- 15.90%
- Shares
- 9,330,878
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Flagship Ventures Fund V, L.P. | 15.90% | 9,330,878 |
| Flagship Ventures Fund V General Partner LLC | 15.90% | 9,330,878 |
| Flagship Ventures Opportunities Fund I, L.P. | 2.50% | 1,491,441 |
| Flagship Ventures Opportunities Fund I General Partner LLC | 2.50% | 1,491,441 |
| Flagship Pioneering Special Opportunities Fund II, L.P. | 3.20% | 3,666,715 |
| Flagship Pioneering Special Opportunities Fund II General Partner LLC | 3.20% | 3,666,715 |
| Flagship Pioneering Fund VII, L.P. | 7.10% | 6,285,851 |
| Flagship Pioneering Fund VII General Partner LLC | 7.10% | 6,285,851 |
| Flagship Pioneering, LLC | 10.00% | 9,952,566 |
| Noubar Afeyan | 27.20% | 20,774,885 |
Source
Related
- Foghorn Therapeutics Inc.
- Flagship Ventures Fund V, L.P.
- Foghorn Therapeutics Inc. shareholders
- Schedule 13G/A · Bvf Partners L P · Oct 5, 2026
- Schedule 13G/A · Bvf Partners L P · May 15, 2026
- Schedule 13G/A · Deerfield Mgmt, L.P. · May 14, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Form 4 · Gottschalk Adrian · Apr 13, 2026